Britannia Life Sciences Inc
F:L020
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0165
0.071
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one L020 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.038 EUR, Britannia Life Sciences Inc is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Britannia Life Sciences Inc
L020 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether L020 usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Britannia Life Sciences Inc.
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Britannia Life Sciences Inc
Balance Sheet Decomposition
Britannia Life Sciences Inc
| Current Assets | 8.2m |
| Cash & Short-Term Investments | 6.1m |
| Receivables | 201.6k |
| Other Current Assets | 1.8m |
| Non-Current Assets | 1.7m |
| Long-Term Investments | 1.5m |
| PP&E | 128.1k |
| Current Liabilities | 2.6m |
| Accounts Payable | 2.4m |
| Short-Term Debt | 123.7k |
| Other Current Liabilities | 76.6k |
| Non-Current Liabilities | 1.6m |
| Long-Term Debt | 1.6m |
Free Cash Flow Analysis
Britannia Life Sciences Inc
| CAD | |
| Free Cash Flow | CAD |
Earnings Waterfall
Britannia Life Sciences Inc
|
Revenue
|
3.9m
CAD
|
|
Cost of Revenue
|
-1.5m
CAD
|
|
Gross Profit
|
2.4m
CAD
|
|
Operating Expenses
|
-2.3m
CAD
|
|
Operating Income
|
35k
CAD
|
|
Other Expenses
|
-2.1m
CAD
|
|
Net Income
|
-2m
CAD
|
L020 Profitability Score
Profitability Due Diligence
Britannia Life Sciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Britannia Life Sciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
L020 Solvency Score
Solvency Due Diligence
Britannia Life Sciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Britannia Life Sciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
L020 Price Targets Summary
Britannia Life Sciences Inc
Dividends
Current shareholder yield for BLAB is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one L020 stock under the Base Case scenario is hidden EUR.
Compared to the current market price of 0.038 EUR, Britannia Life Sciences Inc is hidden .